Ensysce Biosciences Inc Share Price

NASDAQ: ENSC

Small Cap

$2.06

-0.04

(-2.13%)

as on September 16, 2025 at 1:29 am IST

$₹

Ensysce Biosciences Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$2.03
Day's Price Range
$2.12
$2.06
1.46%
Downside
2.91%
Upside
52 Week's Low
52 Week's High
$1.62
52-Week Price Range
$14.67
$2.06
21.36%
Downside
612.14%
Upside

Ensysce Biosciences Inc share price movements today

Previous Close: $2.11
Open: $2.12
Volume: 309.3K
Day's Low - High: $2.03 - $2.12
52 Week Low - High: $1.62 - $14.67

Ensysce Biosciences Inc Historical Returns

1 Month Return: + 0.98 %
3 Month Return: -3.72 %
1 Year Return: -60 %
3 Year Return: -99.82 %
5 Year Return: 0 %

Ensysce Biosciences Inc Stock Fundamentals & Key Indicators

Check Ensysce Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.3M

EPS (TTM)

-4.32

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.31

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-24.2M

Revenue (TTM)

7.4M

Profit Margin

-88.78%

Return On Equity TTM

20872900.00%

Ensysce Biosciences Inc Stock Valuation

Track how Ensysce Biosciences Inc P/E has moved over time to understand its valuation trends.

Ensysce Biosciences Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 16, 2025

Industry (0.00x)

September 16, 2025

Today (-0.31x)

September 16, 2025

Highest (0.00x)

September 16, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.31x

Ensysce Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ensysce Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ensysce Biosciences Inc	BUY	$6.3M	NA	-0.31	-88.78%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Ensysce Biosciences Inc Stock including INR - Dollar returns

The Ensysce Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ensysce Biosciences Inc investment value today

Current value as on today

₹44,713

Returns

₹55,287

(-55.29%)

Returns from Ensysce Biosciences Inc Stock

₹60,155 (-60.15%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Ensysce Biosciences Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Ensysce Biosciences Inc. Average target price of $20.23

Ensysce Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Ensysce Biosciences Inc.

What analysts predicted

89.82%UPSIDE

Target Price

$20.23

Current Price

$2.06

Analyzed by

7 Analysts

Target

$20.23

Ensysce Biosciences Inc target price $20.23, a slight upside of 89.82% compared to current price of $2.06. According to 7 analysts rating.

Ensysce Biosciences Inc Stock's Interest Amongst Investors

Search interest for Ensysce Biosciences Inc Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-53% versus previous 30 day period

Ensysce Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	3	1	1	1
Gross Profit	-1	-1	-1	-1	0	0	1	-2	1	-
Operating Income	-2	-2	-2	-3	-1	-1	0	-3	-1	-1
EBITDA	-2	-2	-2	-3	-1	-1	0	-3	-1	-1
Interest Expense	0	-	0	0	1	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-2	-2	-3	-3	-1	0	-3	-1	-1
Income Tax Expense	0	0	0	0	0	0	-	0	-	-
Net Income	-2	-2	-2	-3	-3	-1	0	-3	-1	-1
Net Profit Margin	-277.09%	-455.07%	-617.85%	-680.15%	-1019.23%	-1082.53%	19.36%	-273.31%	-147.42%	-126.39%

Ensysce Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	1	3	3	2	2	5
Gross Profit	-	-1	-3	3	3	-17	-5	-2
Operating Income	0	0	-3	-1	-19	-24	-10	-6
EBITDA	0	0	-3	-1	-19	-24	-10	-6
Interest Expense	-	-	-	0	1	0	0	1
Depreciation	-	-	-	0	0	-	-	-
Income Before Tax	0	2	0	0	-29	-24	-10	-7
Income Tax Expense	0	0	0	0	0	0	0	-
Net Income	0	2	1	0	-29	-24	-10	-7
Net Profit Margin	0.00%	0.00%	83.70%	1.44%	-825.38%	-989.21%	-475.71%	-153.30%

Ensysce Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	-2	-3	-3	-1	0	-3	-1	-1
Operating Cash Flow	-3	-2	-1	-3	-2	-1	0	-1	-2
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	5	0	1	5	0	4	0	1	1
Change in Cash	2	-2	0	2	-2	3	0	0	0

Ensysce Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	0	0	-29	-24	-10	-7
Operating Cash Flow	-1	10	-1	-8	-17	-10	-7,502,700
Investing Cash Flow	0	0	183	-	0	-	-
Financing Cash Flow	0	-11	1	20	8	8	9,881,173
Change in Cash	0	0	0	12	-9	-2	2,378,473

Global Institutional Holdings in Ensysce Biosciences Inc

Funds	Holdings
Murchinson Ltd.	5.91%
Perceptive Advisors LLC	3.66%
Adage Capital Partners Gp LLC	3.15%
Sabby Management LLC	1.98%
FNY Investment Advisers, LLC	0.13%

See all

Insights on Ensysce Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -3.56M → -1.73M (in $), with an average increase of 47.7% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.30M → 1.37M (in $), with an average increase of 2.5% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 216.3%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 130.6%
NEGATIVE IMPACT
Price Dip
In the last 6 months, ENSC stock has moved down by -46.8%

About Ensysce Biosciences Inc

ensysce biosciences, san diego, ca, is an integrated drug delivery company for both small and large molecules. to overcome the major problem of non-medical use of opioid products, ensysce is using its prodrug technology to improve abuse deterrent properties. the tap bio-md™ abuse deterrent and mpar™ overdose resistant pain platforms, with worldwide intellectual patent protection, eliminate the ability to abuse opioid products by the non-oral route. this abuse is the fastest growing drug problem in the u.s. and it leads to billions in healthcare costs annually. for additional information about ensysce biosciences please visit www.ensysce.com.

Organisation	Ensysce Biosciences Inc
Headquarters	7946 Ivanhoe Avenue, La Jolla, CA, United States, 92037
CEO	Dr. D. Lynn Kirkpatrick Ph.D.
E-voting on shares	Click here to vote

Key Management of Ensysce Biosciences Inc

Name	Title
Dr. D. Lynn Kirkpatrick Ph.D.	President, CEO & Director
Mr. David C. Humphrey CPA	CFO, Secretary & Treasurer
Mr. Geoffrey Birkett	Chief Commercial Officer
Dr. Jeffrey Millard Ph.d.	Chief Operating Officer
Dr. William K. Schmidt Ph.D.	Chairman of Clinical Advisory Board & Chief Medical Officer
Dr. Linda Pestano Ph.D.	Chief Development Officer

FAQs

What is Ensysce Biosciences Inc share price today?

Ensysce Biosciences Inc share price today is $2.06 as on September 16, 2025 at 1:29 am IST at the close of the market. Ensysce Biosciences Inc share today touched a day high of $2.12 and a low of $2.03.

What is the 52 week high and 52 week low for Ensysce Biosciences Inc share?

Ensysce Biosciences Inc share touched a 52 week high of $14.67 on November 7, 2024 and a 52 week low of $1.62 on April 21, 2025. Ensysce Biosciences Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $2.06,which is 85.96% down from its 52 week high and 27.16% up from its 52 week low.

What is Ensysce Biosciences Inc's market capitalisation today?

Ensysce Biosciences Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Ensysce Biosciences Inc Stock (ENSC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ensysce Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ensysce Biosciences Inc Shares that will get you 0.7282 shares as per Ensysce Biosciences Inc share price of $2.06 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ensysce Biosciences Inc Stock (ENSC) from India?

Indian investors can start investing in Ensysce Biosciences Inc (ENSC) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 6:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Ensysce Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 6:38 pm IST). Based on Ensysce Biosciences Inc share’s latest price of $2.06 as on September 16, 2025 at 1:29 am IST, you will get 4.8544 shares of Ensysce Biosciences Inc. Learn more about fractional shares .